<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=129980757405201&amp;ev=PageView&amp;noscript=1">
  TRC-logo.png
Shingrix: a New Herpes

Zoster Vaccine
ShingrixNewZosterVaccine.png

 

 

Fill out the form to watch the webinar now

This TRC Hot Topic webinar features an expert panel discussion on Shingrix, a new herpes zoster vaccine. Listen as Kathleen Dooling, MD, MPH and Adam Welch, PharmD, MBA, BCACP, FAPhA, along with other panelists, answer common clinical questions about the new vaccine, including:

  • How does the efficacy of Shingrix compare to Zostavax?
  • How do Shingrix and Zostavax vaccine formulations differ?
  • Should Shingrix be used instead of Zostavax?
  • Will insurance companies pay for Shingrix instead of Zostavax?
  • Do injection-site reactions differ between Shingrix and Zostavax?